Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Weiye Li MD, PhD

Weiye Li MD, PhD

Professor Emeritus of Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania; Physician, Drexel Eye Physicians, Philadelphia, Pennsylvania

Dr. Weiye Li is an Emeritus Professor of Ophthalmology at Drexel University College of Medicine. He served as the Director of both Ophthalmic Research and Retina Services at Drexel.

Dr. Weiye Li received his medical degree from the Second Medical College of Beijing, China, and received his doctorate from the University of Pennsylvania in Philadelphia. He completed a fellowship in retina vitreous diseases at Crozer-Chester Medical Center, Upland, Pennsylvania. Dr. Li was previously Chairman of the Department of Ophthalmology at Peking Union Medical College Hospital, one of the most competitive and internationally respected medical colleges in the People's Republic of China.

Dr. Li’s basic and clinical research focuses on diabetic retinopathy and age-related macular degeneration He is widely published in the field of ophthalmology and has earned many honors and awards for his research. He is also active in many organizations, including the Association of Research in Vision and Ophthalmology.

Recent Contributions to PracticeUpdate:

  1. Dexamethasone Implant for Diabetic Macular Edema in Naïve vs Refractory Eyes
  2. IRay Therapy as an Adjuvant in Newly Diagnosed nAMD
  3. Mortality After a Cerebrovascular Event in AMD Patients Treated With Intravitreal Bevacizumab
  4. Accuracy and Precision of Anti-VEGF Volume Delivery via Intravitreal Injection
  5. Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative AMD
  6. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
  7. Consistent Long-Term Therapy of Neovascular AMD Managed by ≥50 Anti-VEGF Injections Using a Treat-Extend-Stop Protocol
  8. Targeted Retinal Photocoagulation for Diabetic Macular Edema With Peripheral Retinal Nonperfusion
  9. Optical Density of Subretinal Fluid as a Predictive Biomarker for Eyes With Chronic Central Serous Retinopathy Treated With Eplerenone
  10. Ranibizumab Combined With Laser Photocoagulation Is Safe and Effective in NPDR and PDR Patients With DME

Most Read This Week

Recently Updated